viernes, 14 de agosto de 2020

Scholar Rock's experimental SMA therapy nabs speedy review voucher. (FierceBiotech)

The Readout
Damian Garde & Meghana Keshavan

More reads

  • Thermo Fisher's Qiagen bid fails after target gets COVID testing boost (Reuters)
  • Scholar Rock's experimental SMA therapy nabs speedy review voucher. (FierceBiotech)

No hay comentarios: